Chemical Industry Gilead Sciences and Vir Biotechnology Join Forces in Multi-Billion-Dollar Deal to Advance Next-Generation Solid Tumour Therapies LONDON/FOSTER CITY — In a major strategic play highlighting the pharmaceutical industry’s surging interest in… Nana MuazinOctober 16, 2026
